treatments

Discover Medicines With the Power of AI: Profluent, Fueled by Salesforce Research and Endorsed by Jeff Dean

Gettyimages 1288172035
Last year, Salesforce, the company best known for its cloud sales support software (and Slack), spearheaded a project called ProGen to design proteins using generative AI. “Many drugs — enzymes and antibodies, for example — consist of proteins,” Madani said. Fed into a generative AI model, data about proteins can be used to predict entirely new proteins with novel functions. Other companies and research groups have demonstrated viable ways in which generative AI can be used to predict proteins. And DeepMind, Google’s AI research lab, has a system called AlphaFold that predicts complete protein structures, achieving speed and accuracy far surpassing older, less complex algorithmic methods.

Revolutionary Skincare: SynFlora’s Pursuit of Bioengineering

Synflora
Biotech startup SynFlora brought an enticing pitch for a new type of skin treatment technology to 4YFN at the MWC tradeshow in Barcelona this week. The Spanish startup, whose three co-founders all have PhDs, is working to improve understanding of the skin’s microbiome and engineer skin microbes with the goal of enabling more targeted and novel therapeutics. Including things that range well beyond what we might consider skincare. ), per Knōdlseder, or even vaccines and anti-inflammatory treatments. But the co-founders suggest they could be between one to three years away from their novel system powering a new generation of skin-delivered therapeutics.